Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Advisors
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Biomarker Capture Platform
SubB2M Pan-Cancer Probe
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Business Development
Products
Our Products
hTERT ICC Test
EXO-NET® Pan-Exosome
Product Technology & Features
Workflow and Performance
Product Ordering
Resources
Pipeline
Development Pipeline
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
Media
INOVIQ in the News
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
Conferences & Events
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
2017
14-Dec-2022
Resignation of Director
13-Dec-2022
Positive EXO-NET Results in Ovarian Cancer
5-Dec-2022
MST Access Diagnostics Forum Presentation
30-Nov-2022
Change in substantial holding
28-Nov-2022
Results of 2022 Annual General Meeting
28-Nov-2022
CEO AGM Presentation
28-Nov-2022
INOVIQ Settles Legal Proceedings
25-Nov-2022
Commercial and R&D Update
10-Nov-2022
Healthcare Conference Investor Presentation
4-Nov-2022
Appendix 4C - Statement pursuant to Listing Rule 4.7C.3
1
2
3
4
5
6
Next
